VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 701 filers reported holding VANECK VECTORS ETF TR in Q2 2021. The put-call ratio across all filers is 1.04 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $267,000 | -7.9% | 9,060 | 0.0% | 0.14% | -15.6% |
Q2 2021 | $290,000 | -74.3% | 9,060 | -71.1% | 0.17% | -76.6% |
Q4 2020 | $1,129,000 | -44.6% | 31,333 | -39.8% | 0.72% | -49.3% |
Q3 2020 | $2,039,000 | +10.8% | 52,078 | +3.8% | 1.41% | +1.4% |
Q2 2020 | $1,840,000 | +100.7% | 50,169 | +26.0% | 1.39% | +64.2% |
Q1 2020 | $917,000 | +17.6% | 39,820 | +49.5% | 0.85% | +39.1% |
Q4 2019 | $780,000 | +4.0% | 26,637 | -5.1% | 0.61% | -7.9% |
Q3 2019 | $750,000 | +34.4% | 28,069 | +12.9% | 0.66% | +53.1% |
Q1 2019 | $558,000 | -69.9% | 24,870 | -70.5% | 0.43% | -58.3% |
Q1 2018 | $1,855,000 | -34.7% | 84,403 | -30.9% | 1.03% | -35.2% |
Q4 2017 | $2,839,000 | -9.5% | 122,150 | -10.6% | 1.60% | -9.4% |
Q3 2017 | $3,137,000 | -6.4% | 136,623 | -10.0% | 1.76% | -8.5% |
Q2 2017 | $3,352,000 | -1.3% | 151,809 | +2.0% | 1.92% | -7.8% |
Q1 2017 | $3,395,000 | +20.3% | 148,844 | +10.4% | 2.09% | +6.9% |
Q4 2016 | $2,821,000 | -47.5% | 134,846 | -33.7% | 1.95% | -46.1% |
Q3 2016 | $5,375,000 | -3.3% | 203,375 | +1.4% | 3.63% | -8.5% |
Q2 2016 | $5,557,000 | – | 200,556 | – | 3.96% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Memorial Sloan Kettering Cancer Center | 738,500 | $20,220,000 | 66.82% |
Baymount Management LP | 145,000 | $3,970,000 | 28.08% |
New Harbor Financial Group, LLC | 1,371,341 | $37,547,000 | 18.51% |
New Harbor Financial Group, LLC | 1,291,700 | $35,366,000 | 17.44% |
MKP Capital Management, L.L.C. | 1,500,000 | $41,070,000 | 13.74% |
Windmill Hill Asset Management Ltd | 844,600 | $23,125,000 | 11.94% |
Hollow Brook Wealth Management LLC | 768,567 | $21,043,000 | 11.57% |
Grand Central Investment Group | 261,915 | $7,171,000 | 10.33% |
Point72 Europe (London) LLP | 1,467,000 | $40,166,000 | 8.50% |
Slate Path Capital LP | 4,600,000 | $125,948,000 | 7.87% |